Your browser doesn't support javascript.
loading
Liver transplantation for iatrogenic bile duct injury: a systematic review.
Spiers, Harry V M; Lam, Shi; Machairas, Nikolaos A; Sotiropoulos, Georgios C; Praseedom, Raaj K; Balakrishnan, Anita.
Afiliação
  • Spiers HVM; Department of Surgery, Addenbrooke's Hospital and the University of Cambridge, Cambridge, United Kingdom.
  • Lam S; Department of Surgery, Addenbrooke's Hospital and the University of Cambridge, Cambridge, United Kingdom.
  • Machairas NA; 2nd Department of Propaedeutic Surgery, General Hospital Laiko, National and Kapodistrian University of Athens, Greece.
  • Sotiropoulos GC; 2nd Department of Propaedeutic Surgery, General Hospital Laiko, National and Kapodistrian University of Athens, Greece.
  • Praseedom RK; Department of Surgery, Addenbrooke's Hospital and the University of Cambridge, Cambridge, United Kingdom.
  • Balakrishnan A; Department of Surgery, Addenbrooke's Hospital and the University of Cambridge, Cambridge, United Kingdom. Electronic address: ab2031@cam.ac.uk.
HPB (Oxford) ; 25(12): 1475-1481, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37633743
ABSTRACT

BACKGROUND:

Bile duct injury (BDI) is an infrequent but serious complication of cholecystectomy, often with life-changing consequences. Liver transplantation (LT) may be required following severe BDI, however given the rarity, few large studies exist to guide management for complex BDI.

METHODS:

A systematic review was performed to assess post-operative complications, 30-day mortality, retransplant rate and 1-year and 5-year survival following LT for BDI in Medline, EMBASE, Web of Science or Cochrane Clinical Trials Database.

RESULTS:

Seven articles met inclusion criteria, describing 179 patients that underwent LT for BDI. Secondary biliary cirrhosis (SBC) was the main indication for LT (82.2% of patients). Median model for end-stage liver disease (MELD) scores at time of LT ranged from 16 to 20.5. Median 30-day mortality was 20.0%. The 1-year and 5-year survival ranges were 55.0-84.3% and 30.0-83.3% respectively, and the overall retransplant rate was 11.5%.

CONCLUSION:

BDI is rarely indicated for LT, predominantly for SBC following multiple prior interventions. MELD scores poorly reflect underlying morbidity, and exception criteria for waitlisting may avoid prolonged LT waiting times. 30-day mortality was higher than for non-BDI indications, with comparable long term survival, suggesting that LT remains a viable but high risk salvage option for severe BDI.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças dos Ductos Biliares / Transplante de Fígado / Colecistectomia Laparoscópica / Doença Hepática Terminal / Cirrose Hepática Biliar Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: HPB (Oxford) Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças dos Ductos Biliares / Transplante de Fígado / Colecistectomia Laparoscópica / Doença Hepática Terminal / Cirrose Hepática Biliar Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: HPB (Oxford) Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido